From Casetext: Smarter Legal Research

Errant Gene Therapeutics, LLC v. Sloan-Kettering Inst. for Cancer Research & Bluebird Bio Inc.

Appellate Division of the Supreme Court of the State of New York
Jul 23, 2019
2019 N.Y. Slip Op. 75856 (N.Y. App. Div. 2019)

Opinion

Motion No: M-2956

07-23-2019

Errant Gene Therapeutics, LLC, Plaintiff-Respondent, v. Sloan-Kettering Institute for Cancer Research and Bluebird Bio Inc., Defendants-Appellants.


Appeals having been taken to this Court from the order and so-ordered transcript of the Supreme Court, New York County, entered on or about June 4, 2019, And defendant-appellant Bluebird Bio Inc. having moved for a stay of trial and associated deadlines for pre-trial filings, pending hearing and determination of the aforesaid appeal,Now, upon reading and filing the papers with respect to the motion, and due deliberation having been had thereon, It is ordered that the motion is granted.

ENTERED: July 23, 2019

__________ CLERK

Present - Hon. John W. Sweeny, Jr.,Justice Presiding, Dianne T. Renwick Rosalyn H. Richter Sallie Manzanet-Daniels Peter Tom,Justices

M-2956

Index No. 150856/17


Summaries of

Errant Gene Therapeutics, LLC v. Sloan-Kettering Inst. for Cancer Research & Bluebird Bio Inc.

Appellate Division of the Supreme Court of the State of New York
Jul 23, 2019
2019 N.Y. Slip Op. 75856 (N.Y. App. Div. 2019)
Case details for

Errant Gene Therapeutics, LLC v. Sloan-Kettering Inst. for Cancer Research & Bluebird Bio Inc.

Case Details

Full title:Errant Gene Therapeutics, LLC, Plaintiff-Respondent, v. Sloan-Kettering…

Court:Appellate Division of the Supreme Court of the State of New York

Date published: Jul 23, 2019

Citations

2019 N.Y. Slip Op. 75856 (N.Y. App. Div. 2019)